» Articles » PMID: 16904903

The C-Myc Target Gene Network

Overview
Specialty Oncology
Date 2006 Aug 15
PMID 16904903
Citations 593
Authors
Affiliations
Soon will be listed here.
Abstract

For more than a decade, numerous studies have suggested that the c-Myc oncogenic protein is likely to broadly influence the composition of the transcriptome. However, the evidence required to support this notion was made available only recently, much to the anticipation of an eagerly awaiting field. In the past 5 years, many high-throughput screens based on microarray gene expression profiling, serial analysis of gene expression (SAGE), chromatin immunoprecipitation (ChIP) followed by genomic array analysis, and Myc-methylase chimeric proteins have generated a wealth of information regarding Myc responsive and target genes. From these studies, the c-Myc target gene network is estimated to comprise about 15% of all genes from flies to humans. Both genomic and functional analyses of c-Myc targets suggest that while c-Myc behaves as a global regulator of transcription, groups of genes involved in cell cycle regulation, metabolism, ribosome biogenesis, protein synthesis, and mitochondrial function are over-represented in the c-Myc target gene network. c-Myc also consistently represses genes involved in cell growth arrest and cell adhesion. The overexpression of c-Myc predisposes cells to apoptosis under nutrient or growth factor deprivation conditions, although the critical sets of genes involved remain elusive. Despite tremendous advances, the downstream target genes that distinguish between physiologic and tumorigenic functions of c-Myc remain to be delineated.

Citing Articles

Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target.

Sias F, Zoroddu S, Migheli R, Bagella L Int J Mol Sci. 2025; 26(5).

PMID: 40076599 PMC: 11900228. DOI: 10.3390/ijms26051973.


Adipose-derived stem cells attenuate rheumatoid arthritis by restoring CXCR1 synovial lining macrophage barrier.

Wang L, Hao M, Xu Y, Wang Z, Xie H, Zhang B Stem Cell Res Ther. 2025; 16(1):111.

PMID: 40038808 PMC: 11881422. DOI: 10.1186/s13287-025-04144-5.


Unveiling the effects of GSK126 on osteosarcoma cells implications for apoptosis, autophagy, and cellular migration.

Xiong X, Liu Y, Du Y, Lai X, Si C, Miao H Discov Oncol. 2025; 16(1):245.

PMID: 40014170 PMC: 11868014. DOI: 10.1007/s12672-025-02010-7.


Salicylate-Elicited Activation of AMP-Activated Protein Kinase Directly Triggers Degradation of C-Myc in Colorectal Cancer Cells.

Matos A, Ovens A, Jakobsen E, Iglesias-Gato D, Bech J, Friis S Cells. 2025; 14(4).

PMID: 39996767 PMC: 11854256. DOI: 10.3390/cells14040294.


CDCA3-MYC positive feedback loop promotes bladder cancer progression via ENO1-mediated glycolysis.

Shen D, Yu X, Fan X, Liang Y, Lu D, Ke Z J Exp Clin Cancer Res. 2025; 44(1):63.

PMID: 39980052 PMC: 11841255. DOI: 10.1186/s13046-025-03325-7.